<a href="https://www.fiercebiotech.com/biotech/incyte-pays-genesis-80m-expand-ai-fueled-drug-discovery-pact" hreflang="en">Incyte pays Genesis $80M to expand AI-fueled drug discovery pact</a>
fiercebiotech.com·May 20, 2026
Incyte is investing $80 million upfront to enhance the use of Genesis's AI platform for drug discovery and development, reflecting the biotech's growing integration of AI technology.
Incyte's $80 million investment in Genesis's AI platform underscores the growing trend of biotech companies rapidly integrating AI into drug discovery processes. For someone tracking AI drug discovery, this signals a significant opportunity for partnerships and investments in AI technologies that enhance target identification and drug development efficiency.